Jefferies Group Analysts Reduce Earnings Estimates for Dentsply Sirona (XRAY)

Dentsply Sirona (NASDAQ:XRAY) – Analysts at Jefferies Group reduced their Q1 2018 EPS estimates for Dentsply Sirona in a research report issued to clients and investors on Monday, April 16th. Jefferies Group analyst B. Couillard now anticipates that the medical instruments supplier will post earnings of $0.43 per share for the quarter, down from their previous forecast of $0.47. Jefferies Group currently has a “Buy” rating on the stock. Jefferies Group also issued estimates for Dentsply Sirona’s Q4 2018 earnings at $0.88 EPS, FY2018 earnings at $2.71 EPS, Q1 2019 earnings at $0.65 EPS, Q2 2019 earnings at $0.74 EPS, Q3 2019 earnings at $0.77 EPS and Q4 2019 earnings at $0.84 EPS.

How to Become a New Pot Stock Millionaire

A number of other equities research analysts have also weighed in on the company. Cleveland Research reaffirmed a “hold” rating on shares of Dentsply Sirona in a research report on Thursday, April 5th. Barrington Research reissued a “buy” rating and issued a $69.00 price target on shares of Dentsply Sirona in a research report on Tuesday, March 27th. HC Wainwright set a $63.00 price target on Dentsply Sirona and gave the stock a “hold” rating in a research report on Tuesday, March 27th. Barclays began coverage on Dentsply Sirona in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $62.00 price target for the company. Finally, JPMorgan Chase reduced their price target on Dentsply Sirona from $75.00 to $70.00 and set an “overweight” rating for the company in a research report on Monday, March 5th. Three research analysts have rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $67.36.

Shares of NASDAQ XRAY opened at $50.19 on Tuesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.10 and a quick ratio of 1.45. The firm has a market cap of $11,141.04, a price-to-earnings ratio of 18.87, a PEG ratio of 2.16 and a beta of 1.26. Dentsply Sirona has a twelve month low of $48.25 and a twelve month high of $68.98.

Dentsply Sirona (NASDAQ:XRAY) last issued its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.81 by $0.01. The business had revenue of $1.09 billion during the quarter, compared to analyst estimates of $1.06 billion. Dentsply Sirona had a positive return on equity of 8.35% and a negative net margin of 39.39%. Dentsply Sirona’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.67 EPS.

Several institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. BlackRock Inc. increased its position in Dentsply Sirona by 0.7% during the 4th quarter. BlackRock Inc. now owns 14,169,813 shares of the medical instruments supplier’s stock valued at $932,797,000 after buying an additional 104,894 shares in the last quarter. Generation Investment Management LLP increased its position in Dentsply Sirona by 115.6% during the 4th quarter. Generation Investment Management LLP now owns 9,011,670 shares of the medical instruments supplier’s stock valued at $593,238,000 after buying an additional 4,831,112 shares in the last quarter. Clearbridge Investments LLC increased its position in Dentsply Sirona by 5.1% during the 4th quarter. Clearbridge Investments LLC now owns 6,958,367 shares of the medical instruments supplier’s stock valued at $458,069,000 after buying an additional 340,634 shares in the last quarter. Jackson Square Partners LLC increased its position in Dentsply Sirona by 8.8% during the 4th quarter. Jackson Square Partners LLC now owns 6,891,530 shares of the medical instruments supplier’s stock valued at $453,669,000 after buying an additional 556,624 shares in the last quarter. Finally, Viking Global Investors LP increased its position in Dentsply Sirona by 51.9% during the 4th quarter. Viking Global Investors LP now owns 5,397,707 shares of the medical instruments supplier’s stock valued at $355,331,000 after buying an additional 1,844,190 shares in the last quarter. 97.79% of the stock is owned by hedge funds and other institutional investors.

The business also recently declared a quarterly dividend, which was paid on Friday, April 13th. Stockholders of record on Thursday, March 29th were given a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend was Wednesday, March 28th. Dentsply Sirona’s payout ratio is 13.16%.

ILLEGAL ACTIVITY WARNING: This report was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.chaffeybreeze.com/2018/04/17/jefferies-group-analysts-reduce-earnings-estimates-for-dentsply-sirona-xray.html.

About Dentsply Sirona

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Earnings History and Estimates for Dentsply Sirona (NASDAQ:XRAY)

Receive News & Ratings for Dentsply Sirona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply Sirona and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply